Exubrion Therapeutics
Get Full AccessDescription
- We are a dedicated team of animal health professionals with a passion for solving the challenges of managing chronic pain in companion animals. We are harnessing the power of the novel radiotherapeutic device Synovetin OA (tin-117m) to treat canine elbow arthritis. Synovetin OA targets inflammatory macrophages in the synovium and synovial fluid to break the cycle of inflammation and provide very long-lasting relief and improved mobility. Synovetin OA is administered in a minimally-invasive, outpatient procedure, convenient for the pet, pet parent and veterinary professional.
-
Headquarters:5203 Bristol Industrial Way , Buford, Georgia, United States
More -
Phone Number:
-
Website: http://www.synovetin.com
-
Employees:10
-
Revenue:$1 - 10M
-
Legal Name:Exubrion Therapeutics
-
Exubrion Therapeutics's Social Media
- Is this data correct?
-
| NAICS Code: 115210 |
Show More
Frequently Asked Questions regarding Exubrion Therapeutics
-
Where are Exubrion Therapeutics's Headquarters?
Exubrion Therapeutics's Headquarters are in 5203 Bristol Industrial Way ,Buford,Georgia,United States
-
What is Exubrion Therapeutics's official website?
Exubrion Therapeutics's official website is http://www.synovetin.com
-
What is Exubrion Therapeutics's Revenue?
Exubrion Therapeutics's revenue is $1 - 10M
-
What is Exubrion Therapeutics's NAICS code?
Exubrion Therapeutics's NAICS code is 115210
-
How many employees are working in Exubrion Therapeutics
Exubrion Therapeutics has 10 employees
-
What is Exubrion Therapeutics's Industry?
Exubrion Therapeutics is in the industry of Veterinary
-
Who is Exubrion Therapeutics's CEO?
Exubrion Therapeutics's CEO is Peter Selover
-
Who is Exubrion Therapeutics's Chief Commercial Officer?
Exubrion Therapeutics's Chief Commercial Officer is Eric Schreiber